Neonatal immune challenge exacerbates seizure-induced hippocampus-dependent memory impairment in adult rats

Ping Yin1, Zhen Li, Ying-Yan Wang

  • 1Pediatric Department of Qilu Hospital, Shandong University, Jinan, China.

Epilepsy & Behavior : E&B
|January 29, 2013
PubMed

Insights

Neonatal exposure to lipopolysaccharide (LPS) primes microglia, leading to heightened neuroinflammation and worse behavioral outcomes after seizures in adulthood. Minocycline treatment mitigated these effects, suggesting a therapeutic window.

Area of Science:

  • Neuroscience
  • Immunology
  • Developmental Biology

Background:

  • Microglia, the brain's resident immune cells, play a critical role in neuroinflammation.
  • Neonatal immune challenges may have long-lasting effects on brain development and function.
  • Understanding the link between early-life inflammation and later neurological disorders is crucial.

Purpose of the Study:

  • To investigate the impact of neonatal lipopolysaccharide (LPS) exposure on microglia activation.
  • To determine if neonatal LPS exposure influences neurobehavioral outcomes following seizures in adulthood.
  • To evaluate the therapeutic potential of minocycline in mitigating LPS-induced effects.

Main Methods:

  • Neonatal male rat pups were injected with LPS or saline on postnatal days 3 and 5.
  • Microglia activation was assessed using immunohistochemistry.
  • Seizures were induced at postnatal day 45 using kainic acid (KA); neurobehavioral tests (Y-maze, Morris water maze, inhibitory avoidance) were performed.

Main Results:

  • Neonatal LPS exposure led to persistent microglia activation into adolescence.
  • LPS-treated rats exhibited increased proinflammatory responses and poorer performance in behavioral tasks after KA-induced seizures.
  • Minocycline treatment during the neonatal period attenuated neuroinflammation and improved memory deficits.

Conclusions:

  • Neonatal immune activation primes the brain, predisposing it to exacerbated behavioral deficits after seizures.
  • Priming of microglia by early-life inflammation may underlie these long-term consequences.
  • Targeting microglia activation early in life holds therapeutic promise for seizure-related neurological impairments.

Related Concept Videos